Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.

about

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.

Item

http://www.wikidata.org/entity/Q54977578

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.

@en

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.

@nl

type

Item

label

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.

@en

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.

@nl

prefLabel

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.

@en

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma.

@nl

P1476

Tumor Reduction with Pazopanib in a Patient with Recurrent Lumbar Chordoma

@en

P2093

Ceci Obara Kurimori

http://www.w3.org/2001/XMLSchema#string

Luiz Guilherme Cernaglia Aureliano de Lima

http://www.w3.org/2001/XMLSchema#string

Marcos Vinicius Calfat Maldaun

http://www.w3.org/2001/XMLSchema#string

Micelange Carvalho de Sousa

http://www.w3.org/2001/XMLSchema#string

Romulo Loss Mattedi

http://www.w3.org/2001/XMLSchema#string

Samir Abdallah Hanna

http://www.w3.org/2001/XMLSchema#string

P2860

Chordoma: current concepts, management, and future directions

Imatinib mesylate in chordoma

Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis

Response to imatinib plus sirolimus in advanced chordoma.

Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.

Phase II study of imatinib in advanced chordoma.

Phase II study on lapatinib in advanced EGFR-positive chordoma.

Molecular targeted therapies in advanced or metastatic chordoma patients: facts and hypotheses.

Novel targeted therapies in chordoma: an update.

Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury.

P304

4290131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1155/2018/4290131

http://www.w3.org/2001/XMLSchema#string

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

Maurício Fernando Silva Almeida Ribeiro

Rodrigo Ramella Munhoz

P577

2018-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29850323

http://www.w3.org/2001/XMLSchema#string

P921

chordoma

P932

5914121

http://www.w3.org/2001/XMLSchema#string